AI drug discovery platform raises Series B funding

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Artificial Intelligence In Drug Discovery

AI drug discovery platform raises Series B funding

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

Harnessing artificial intelligence to help prevent epidemics before they spread

These are the biggest trends in clean tech in 2021

EU New Role as Tech Venture Capitalist

Government to nurture AI-specializing medical scientists

Experts discuss barriers to deep tech ventures